Meet your next business partner and infuse your company with a well-deserved supply of operating capital at the ACI’s Advanced Forum on Structuring, Negotiating and Managing Pharma/Biotech Collaborative Agreements, which will be held 14-15 July 2009 at the Sheraton’s Fisherman Wharf in San Francisco, USA.
Designed to provide you with the most up-to-date strategic analysis of current deal structuring and outstanding networking and business development opportunities, you’re bound to walk away with the contacts and intelligence you need to forge successful new alliances and stay strong through the next fiscal year.
An exceptional faculty of diverse speakers will show you how to develop and cultivate lucrative relationships by sharing strategies on and solutions for:
- Capitalising on shifting trends in the venture capital investment landscape
- Forging and protecting lucrative relationships with investors
- Negotiating partnerships with start-up innovators and government programmes
- Contending with increased pressure from anxious investor’s seeking an immediate healthy return on their investment
- Positioning your IP portfolio to increase your market power
- Converting a licensing deal into an acquisition
Industry leaders who will be in attendance include: Astellas, CV Therapeutics, Eisai, Lundbeck, Jazz Pharmaceuticals, Merck, Millennium Pharmaceuticals, NIH, Poniard Pharmaceuticals, Procter and Gamble, Supernus Pharmaceuticals, Sunesis Pharmaceuticals, Trius Therapeutics, University of Utah, and VLST Corp.
Additionally, learn the vital strategies necessary in today’s economic environment by attending the master class, Collaborations in Troubled Times: Structuring a Deal with a Struggling Counterparty.
Join your colleagues and register today for this timely event by visiting the American Conference Institute’s website.